Leukaemia patients were successfully treated with first-in-human “universal” CRISPR-edited T-cells by specialist researchers.
“Universal” CRISPR-edited T cells improve resistant leukaemia
Posted in biotech/medical
Posted in biotech/medical
Leukaemia patients were successfully treated with first-in-human “universal” CRISPR-edited T-cells by specialist researchers.